Global Kidney Chip Supply, Demand and Key Producers, 2026-2032
The global Kidney Chip market size is expected to reach $ 74.30 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
A Kidney Chip, is an in vitro bioengineered platform that combines human renal cells, microfluidic channels, extracellular matrix, porous membranes, and controlled fluid flow to reproduce selected structural and functional characteristics of the human kidney. Depending on the model, the system may simulate the glomerular filtration barrier, proximal-tubule reabsorption and secretion, distal-tubule transport, collecting-duct function, renal vascular interactions, or communication between multiple nephron segments. The platform is used to study kidney physiology, renal diseases, drug transport, pharmacokinetics, and drug-induced nephrotoxicity under more physiologically relevant conditions than conventional two-dimensional cell culture. The market includes empty microfluidic chips, cell-loaded assay-ready kidney models, organoid-on-chip products, perfusion instruments, pumps, controllers, sensors, imaging and analysis software, culture reagents, customized model-development services, and contract testing. Kidney Chips are research and drug-development tools rather than implantable electronic devices, dialysis products, or artificial kidneys used directly for patient treatment.
This report is a detailed and comprehensive analysis of the world market for Kidney Chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Chip that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Kidney Chip market
2. What is the demand of the global Kidney Chip market?
3. What is the year over year growth of the global Kidney Chip market?
4. What is the total value of the global Kidney Chip market?
5. Who are the Major Players in the global Kidney Chip market?
6. What are the growth factors driving the market demand?
A Kidney Chip, is an in vitro bioengineered platform that combines human renal cells, microfluidic channels, extracellular matrix, porous membranes, and controlled fluid flow to reproduce selected structural and functional characteristics of the human kidney. Depending on the model, the system may simulate the glomerular filtration barrier, proximal-tubule reabsorption and secretion, distal-tubule transport, collecting-duct function, renal vascular interactions, or communication between multiple nephron segments. The platform is used to study kidney physiology, renal diseases, drug transport, pharmacokinetics, and drug-induced nephrotoxicity under more physiologically relevant conditions than conventional two-dimensional cell culture. The market includes empty microfluidic chips, cell-loaded assay-ready kidney models, organoid-on-chip products, perfusion instruments, pumps, controllers, sensors, imaging and analysis software, culture reagents, customized model-development services, and contract testing. Kidney Chips are research and drug-development tools rather than implantable electronic devices, dialysis products, or artificial kidneys used directly for patient treatment.
Key Findings
- In 2025, global production of Kidney Chip was approximately 22,599 units.
- Microfluidic renal models reproduce transport and barrier functions under controlled flow
- Proximal tubule models remain the most commercially mature product segment
- Drug-induced nephrotoxicity testing represents the principal downstream application
- Pharmaceutical companies and research institutions form the core customer base
- Standardization and regulatory validation will determine future commercial scalability
Market Trends
Kidney Chip development is moving from simple single-cell microchannels toward multicellular, vascularized, organoid-based, and interconnected renal models. Human primary renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived kidney organoids are increasingly combined with controlled shear stress and extracellular matrices to improve tissue maturation and transporter expression. Another important trend is the transition from low-throughput customized devices to standardized microplate-compatible formats that support automated liquid handling, high-content imaging, and compound screening. Assay-ready models containing qualified cells and validated protocols are reducing the technical barriers faced by pharmaceutical laboratories. Integrated sensors, real-time imaging, artificial-intelligence-assisted image analysis, and multi-omics measurements are expanding the range of functional readouts. Liver-kidney, gut-liver-kidney, and other multi-organ systems are also gaining attention for studying drug metabolism, systemic exposure, renal clearance, and organ-to-organ toxicity. These developments are gradually shifting Kidney Chips from academic proof-of-concept tools toward repeatable preclinical testing platforms.Market Dynamics
Market development is supported by the pharmaceutical industry’s need for human-relevant preclinical models, but constrained by the difficulty of reproducing the kidney’s complex architecture and functions. Conventional animal models and static cell cultures often provide limited prediction of human renal transport and toxicity, creating demand for more representative alternatives. Regulatory interest in new approach methodologies is improving the strategic position of microphysiological systems, encouraging pharmaceutical companies to evaluate Kidney Chips in internal safety and efficacy programs. However, adoption generally begins through pilot projects because users must compare chip-generated results with animal data, traditional cell assays, clinical biomarkers, and historical compound information. The market therefore combines strong technological potential with cautious commercial implementation. Suppliers must demonstrate not only biological performance but also repeatability across batches, stable cell sourcing, practical workflows, analytical robustness, and cost effectiveness. Partnerships among chip developers, cell suppliers, pharmaceutical companies, contract research organizations, academic laboratories, and regulatory bodies are central to market development.Drivers
The principal driver is the need to identify drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can cause development delays, clinical failures, dosage restrictions, and post-market safety concerns, while conventional models may not adequately reproduce human renal transporters, tubular flow, cell polarity, and interactions between epithelial and vascular tissues. Kidney Chips create controlled environments in which drug exposure, shear stress, reabsorption, secretion, barrier integrity, and biomarker release can be measured dynamically. Growing research on chronic kidney disease, acute kidney injury, diabetic nephropathy, polycystic kidney disease, renal fibrosis, and genetic disorders is also increasing demand for disease-relevant human models. Additional support comes from policies promoting alternatives to animal testing, advances in microfluidics and stem-cell biology, improved access to human renal cells, and growing pharmaceutical investment in microphysiological systems. Together, these factors are expanding Kidney Chip applications from exploratory research toward compound screening, mechanistic toxicology, translational studies, and preclinical decision support.Restraints
Kidney Chip commercialization is limited by biological complexity, high development costs, and the absence of universally accepted validation standards. The human kidney contains multiple specialized cell types and nephron segments that perform filtration, secretion, reabsorption, concentration, endocrine regulation, and vascular exchange. Most current models reproduce only selected functions rather than the complete organ. Cell sourcing is another constraint because primary renal cells may show donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic operation can introduce bubbles, evaporation, inconsistent flow, material absorption, contamination, and handling difficulties. Customers may also require specialized pumps, imaging systems, technical training, and application-specific analytical methods. Differences in chip geometry, cell type, medium, flow rate, exposure protocol, and endpoint selection make comparisons between platforms difficult. Until standardized reference compounds, performance criteria, and regulatory pathways become more established, many users will continue to apply Kidney Chips as complementary research tools rather than complete replacements for established preclinical methods.Opportunities
Commercial opportunities are strongest in assay-ready renal models that reduce cell-culture complexity and provide validated, reproducible results. Pharmaceutical companies need scalable solutions for nephrotoxicity screening, renal transporter studies, compound ranking, biomarker evaluation, and mechanistic investigation. Disease-specific models using patient-derived cells or induced pluripotent stem cells could support personalized medicine, rare-disease research, and development of therapies for inherited kidney disorders. Multi-organ platforms connecting the kidney with the liver, intestine, heart, muscle, or immune system offer additional opportunities in pharmacokinetics, drug metabolism, systemic toxicity, and organ-to-organ communication. Suppliers can also expand through contract testing, customized model development, data-analysis services, regulatory consulting, software subscriptions, and cell-and-reagent packages. High-throughput plate formats and compatibility with laboratory automation will improve adoption among large pharmaceutical organizations. China, Japan, and South Korea provide meaningful expansion potential due to their pharmaceutical manufacturing, biomedical research, microfluidics capabilities, and policies supporting non-animal testing technologies. Strategic partnerships with contract research organizations and cell suppliers can accelerate commercialization.Challenges
The most important challenge is producing biologically meaningful data with sufficient reproducibility for pharmaceutical and regulatory decision-making. Kidney tissues must maintain appropriate polarity, transporter expression, barrier function, metabolic activity, and response to physiological flow over the required culture period. Small changes in cell source, extracellular matrix, medium composition, chip material, flow rate, or dosing procedure can alter experimental outcomes. Suppliers must also select endpoints that correlate with clinically relevant kidney injury, including functional transport measurements, permeability, morphology, gene expression, and released biomarkers. Scaling from research prototypes to standardized production requires consistent microfabrication, surface treatment, membrane quality, sterilization, packaging, cell loading, and shipping. Another challenge is balancing physiological complexity with throughput and ease of use; highly realistic models may be difficult to operate, while simplified systems may provide insufficient predictive value. Long-term growth will therefore depend on interlaboratory studies, reference-compound testing, transparent performance criteria, standardized data formats, and clearer regulatory acceptance of Kidney Chip evidence.Industry Chain Analysis
The upstream industry comprises microfluidic polymers and glass, porous membranes, extracellular matrices, coatings, human renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. Upstream quality directly influences cell viability, fluid control, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture chips, integrate perfusion hardware, establish renal cell models, optimize culture protocols, develop software, validate biological functions, and provide assay-ready products or testing services. Their competitiveness depends on the combined capabilities of microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical and cosmetics companies, and regulatory research institutions. Products are distributed through direct technical sales, scientific-instrument distributors, collaborative development agreements, and contract-service models. Training, installation, application development, data interpretation, maintenance, and consumable supply form an important service layer throughout the industry chain.Value Chain Analysis
The physical microfluidic chip represents only one component of the Kidney Chip value chain. Higher value is generally created through biological model construction, qualified cell sourcing, extracellular-matrix optimization, perfusion control, functional validation, assay design, software analysis, and interpretation of translational data. Empty chips and general-purpose perfusion devices provide flexibility for research users but require substantial in-house expertise. Cell-loaded and assay-ready products command greater strategic value because they reduce model-establishment time, improve batch consistency, and allow users to focus on compound testing. Customized development services add further value by adapting models to specific renal diseases, drug mechanisms, biomarkers, or regulatory questions. Data services and application support become increasingly important as customers seek to connect chip results with animal studies, clinical biomarkers, pharmacokinetic models, and decision-making systems. Recurring revenue can be generated from disposable chips, cells, media, reagents, calibration, maintenance, software, and contract assays. Companies controlling both engineering and biological validation are generally better positioned to capture value across the product lifecycle.Segment Insights
By simulated renal structure, Kidney Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models currently represent the most commercially developed segment because they support nephrotoxicity, transporter, secretion, and reabsorption studies. By technical architecture, products include membrane-separated dual-channel chips, matrix-embedded three-dimensional tubular models, organoid-on-chip systems, vascularized models, and bioprinted renal chips. By product form, the market can be classified into empty chips and consumables, cell-loaded assay-ready models, instruments and perfusion systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major application segments include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance analysis, pharmacokinetic and ADME studies, and personalized medicine. Product selection depends on biological complexity, throughput, reproducibility, operating difficulty, and required analytical endpoints.Downstream Market Opportunities
Drug-induced nephrotoxicity testing represents the principal downstream opportunity because pharmaceutical companies need earlier identification of compounds that damage glomerular, tubular, vascular, or interstitial tissues. Kidney Chips can support compound ranking, dose-response analysis, biomarker evaluation, and investigation of renal transport mechanisms. Disease modeling provides another important opportunity, covering acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Renal transport and clearance studies can improve understanding of drug secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ applications enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized treatment selection. Pharmaceutical companies, biotechnology firms, contract research organizations, academic institutions, and regulatory laboratories are the core customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional application areas for renal toxicity assessment.Regional Insights
North America is an important center for Kidney Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe also has a strong industrial base in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney, multi-organ, perfusion, or enabling-system development. The region benefits from established pharmaceutical research, microfluidics expertise, and policies encouraging non-animal methods. Asia-Pacific is developing rapidly as China, Japan, and South Korea expand investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic scientific instruments. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic or three-dimensional organ-chip development in Japan and South Korea. Regional growth will depend on standardized validation, local cell resources, pharmaceutical partnerships, regulatory acceptance, distributor capabilities, and technical-service infrastructure.Competitive Landscape Analysis
The competitive landscape includes dedicated Kidney Chip suppliers, broad organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules based on its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating renal tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney Chip development services, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or kidney-model solutions. In Asia, Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio represent emerging participants in organoid-chip, microfluidic fabrication, and three-dimensional organ-chip technologies. Competition centers on biological relevance, validated renal functions, throughput, ease of operation, cell quality, automation, data analysis, regulatory credibility, and application support rather than on chip manufacturing capacity alone.Report Scope
This report studies the global Kidney Chip demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Kidney Chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Kidney Chip that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Kidney Chip total market, 2021-2032, (USD Million)
- Global Kidney Chip total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Kidney Chip total market, key domestic companies, and share, (USD Million)
- Global Kidney Chip revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Kidney Chip total market by Type, CAGR, 2021-2032, (USD Million)
- Global Kidney Chip total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Kidney Chip market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Kidney Chip Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Kidney Chip Market, Segmentation by Type:
- Glomerulus-on-a-Chip
- Renal Tubule-on-a-Chip
- Others
Global Kidney Chip Market, Segmentation by Channel:
- Single-Channel
- Dual-Channel
Global Kidney Chip Market, Segmentation by Source:
- Primary Human Cell-Based Type
- Immortalized Cell Line-Based Type
- Stem Cell & Organoid-Based Type
Global Kidney Chip Market, Segmentation by Application:
- Hospitals
- Research Institutions
- Universities
- Others
Companies Profiled:
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Draper Laboratory
- Nortis
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
Key Questions Answered
1. How big is the global Kidney Chip market?2. What is the demand of the global Kidney Chip market?
3. What is the year over year growth of the global Kidney Chip market?
4. What is the total value of the global Kidney Chip market?
5. Who are the Major Players in the global Kidney Chip market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Kidney Chip Introduction
1.2 World Kidney Chip Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Kidney Chip Total Market by Region (by Headquarter Location)
1.3.1 World Kidney Chip Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Kidney Chip Revenue (2021-2032)
1.3.3 China Based Company Kidney Chip Revenue (2021-2032)
1.3.4 Europe Based Company Kidney Chip Revenue (2021-2032)
1.3.5 Japan Based Company Kidney Chip Revenue (2021-2032)
1.3.6 South Korea Based Company Kidney Chip Revenue (2021-2032)
1.3.7 ASEAN Based Company Kidney Chip Revenue (2021-2032)
1.3.8 India Based Company Kidney Chip Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Kidney Chip Consumption Value (2021-2032)
2.2 World Kidney Chip Consumption Value by Region
2.2.1 World Kidney Chip Consumption Value by Region (2021-2026)
2.2.2 World Kidney Chip Consumption Value Forecast by Region (2027-2032)
2.3 United States Kidney Chip Consumption Value (2021-2032)
2.4 China Kidney Chip Consumption Value (2021-2032)
2.5 Europe Kidney Chip Consumption Value (2021-2032)
2.6 Japan Kidney Chip Consumption Value (2021-2032)
2.7 South Korea Kidney Chip Consumption Value (2021-2032)
2.8 ASEAN Kidney Chip Consumption Value (2021-2032)
2.9 India Kidney Chip Consumption Value (2021-2032)
3 WORLD KIDNEY CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Kidney Chip Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Kidney Chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Kidney Chip in 2025
3.2.3 Global Concentration Ratios (CR8) for Kidney Chip in 2025
3.3 Kidney Chip Company Evaluation Quadrant
3.4 Kidney Chip Market: Overall Company Footprint Analysis
3.4.1 Kidney Chip Market: Region Footprint
3.4.2 Kidney Chip Market: Company Product Type Footprint
3.4.3 Kidney Chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Kidney Chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Kidney Chip Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Kidney Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Kidney Chip Consumption Value Comparison
4.2.1 United States VS China: Kidney Chip Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Kidney Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Kidney Chip Companies and Market Share, 2021-2026
4.3.1 United States Based Kidney Chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Kidney Chip Revenue, (2021-2026)
4.4 China Based Companies Kidney Chip Revenue and Market Share, 2021-2026
4.4.1 China Based Kidney Chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Kidney Chip Revenue, (2021-2026)
4.5 Rest of World Based Kidney Chip Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Kidney Chip Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Kidney Chip Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Chip Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Glomerulus-on-a-Chip
5.2.2 Renal Tubule-on-a-Chip
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Kidney Chip Market Size by Type (2021-2026)
5.3.2 World Kidney Chip Market Size by Type (2027-2032)
5.3.3 World Kidney Chip Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CHANNEL
6.1 World Kidney Chip Market Size Overview by Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Channel
6.2.1 Single-Channel
6.2.2 Dual-Channel
6.3 Market Segment by Channel
6.3.1 World Kidney Chip Market Size by Channel (2021-2026)
6.3.2 World Kidney Chip Market Size by Channel (2027-2032)
6.3.3 World Kidney Chip Market Size Market Share by Channel (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World Kidney Chip Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Primary Human Cell-Based Type
7.2.2 Immortalized Cell Line-Based Type
7.2.3 Stem Cell & Organoid-Based Type
7.3 Market Segment by Source
7.3.1 World Kidney Chip Market Size by Source (2021-2026)
7.3.2 World Kidney Chip Market Size by Source (2027-2032)
7.3.3 World Kidney Chip Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Kidney Chip Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Research Institutions
8.2.3 Universities
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Kidney Chip Market Size by Application (2021-2026)
8.3.2 World Kidney Chip Market Size by Application (2027-2032)
8.3.3 World Kidney Chip Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Kidney Chip Product and Services
9.1.4 Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 Mimetas
9.2.1 Mimetas Details
9.2.2 Mimetas Major Business
9.2.3 Mimetas Kidney Chip Product and Services
9.2.4 Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mimetas Recent Developments/Updates
9.2.6 Mimetas Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Kidney Chip Product and Services
9.3.4 TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 Valo Health
9.4.1 Valo Health Details
9.4.2 Valo Health Major Business
9.4.3 Valo Health Kidney Chip Product and Services
9.4.4 Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Valo Health Recent Developments/Updates
9.4.6 Valo Health Competitive Strengths & Weaknesses
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Details
9.5.2 CN Bio Innovations Major Business
9.5.3 CN Bio Innovations Kidney Chip Product and Services
9.5.4 CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CN Bio Innovations Recent Developments/Updates
9.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.6 Draper Laboratory
9.6.1 Draper Laboratory Details
9.6.2 Draper Laboratory Major Business
9.6.3 Draper Laboratory Kidney Chip Product and Services
9.6.4 Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Draper Laboratory Recent Developments/Updates
9.6.6 Draper Laboratory Competitive Strengths & Weaknesses
9.7 Nortis
9.7.1 Nortis Details
9.7.2 Nortis Major Business
9.7.3 Nortis Kidney Chip Product and Services
9.7.4 Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nortis Recent Developments/Updates
9.7.6 Nortis Competitive Strengths & Weaknesses
9.8 Xona Microfluidics
9.8.1 Xona Microfluidics Details
9.8.2 Xona Microfluidics Major Business
9.8.3 Xona Microfluidics Kidney Chip Product and Services
9.8.4 Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Xona Microfluidics Recent Developments/Updates
9.8.6 Xona Microfluidics Competitive Strengths & Weaknesses
9.9 SynVivo
9.9.1 SynVivo Details
9.9.2 SynVivo Major Business
9.9.3 SynVivo Kidney Chip Product and Services
9.9.4 SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SynVivo Recent Developments/Updates
9.9.6 SynVivo Competitive Strengths & Weaknesses
9.10 Beijing Daxiang Biotech
9.10.1 Beijing Daxiang Biotech Details
9.10.2 Beijing Daxiang Biotech Major Business
9.10.3 Beijing Daxiang Biotech Kidney Chip Product and Services
9.10.4 Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Beijing Daxiang Biotech Recent Developments/Updates
9.10.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Kidney Chip Industry Chain
10.2 Kidney Chip Upstream Analysis
10.3 Kidney Chip Midstream Analysis
10.4 Kidney Chip Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Kidney Chip Introduction
1.2 World Kidney Chip Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Kidney Chip Total Market by Region (by Headquarter Location)
1.3.1 World Kidney Chip Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Kidney Chip Revenue (2021-2032)
1.3.3 China Based Company Kidney Chip Revenue (2021-2032)
1.3.4 Europe Based Company Kidney Chip Revenue (2021-2032)
1.3.5 Japan Based Company Kidney Chip Revenue (2021-2032)
1.3.6 South Korea Based Company Kidney Chip Revenue (2021-2032)
1.3.7 ASEAN Based Company Kidney Chip Revenue (2021-2032)
1.3.8 India Based Company Kidney Chip Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Kidney Chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Kidney Chip Consumption Value (2021-2032)
2.2 World Kidney Chip Consumption Value by Region
2.2.1 World Kidney Chip Consumption Value by Region (2021-2026)
2.2.2 World Kidney Chip Consumption Value Forecast by Region (2027-2032)
2.3 United States Kidney Chip Consumption Value (2021-2032)
2.4 China Kidney Chip Consumption Value (2021-2032)
2.5 Europe Kidney Chip Consumption Value (2021-2032)
2.6 Japan Kidney Chip Consumption Value (2021-2032)
2.7 South Korea Kidney Chip Consumption Value (2021-2032)
2.8 ASEAN Kidney Chip Consumption Value (2021-2032)
2.9 India Kidney Chip Consumption Value (2021-2032)
3 WORLD KIDNEY CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Kidney Chip Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Kidney Chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Kidney Chip in 2025
3.2.3 Global Concentration Ratios (CR8) for Kidney Chip in 2025
3.3 Kidney Chip Company Evaluation Quadrant
3.4 Kidney Chip Market: Overall Company Footprint Analysis
3.4.1 Kidney Chip Market: Region Footprint
3.4.2 Kidney Chip Market: Company Product Type Footprint
3.4.3 Kidney Chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Kidney Chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Kidney Chip Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Kidney Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Kidney Chip Consumption Value Comparison
4.2.1 United States VS China: Kidney Chip Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Kidney Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Kidney Chip Companies and Market Share, 2021-2026
4.3.1 United States Based Kidney Chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Kidney Chip Revenue, (2021-2026)
4.4 China Based Companies Kidney Chip Revenue and Market Share, 2021-2026
4.4.1 China Based Kidney Chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Kidney Chip Revenue, (2021-2026)
4.5 Rest of World Based Kidney Chip Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Kidney Chip Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Kidney Chip Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Kidney Chip Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Glomerulus-on-a-Chip
5.2.2 Renal Tubule-on-a-Chip
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Kidney Chip Market Size by Type (2021-2026)
5.3.2 World Kidney Chip Market Size by Type (2027-2032)
5.3.3 World Kidney Chip Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CHANNEL
6.1 World Kidney Chip Market Size Overview by Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Channel
6.2.1 Single-Channel
6.2.2 Dual-Channel
6.3 Market Segment by Channel
6.3.1 World Kidney Chip Market Size by Channel (2021-2026)
6.3.2 World Kidney Chip Market Size by Channel (2027-2032)
6.3.3 World Kidney Chip Market Size Market Share by Channel (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World Kidney Chip Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Primary Human Cell-Based Type
7.2.2 Immortalized Cell Line-Based Type
7.2.3 Stem Cell & Organoid-Based Type
7.3 Market Segment by Source
7.3.1 World Kidney Chip Market Size by Source (2021-2026)
7.3.2 World Kidney Chip Market Size by Source (2027-2032)
7.3.3 World Kidney Chip Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Kidney Chip Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Research Institutions
8.2.3 Universities
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Kidney Chip Market Size by Application (2021-2026)
8.3.2 World Kidney Chip Market Size by Application (2027-2032)
8.3.3 World Kidney Chip Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Kidney Chip Product and Services
9.1.4 Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 Mimetas
9.2.1 Mimetas Details
9.2.2 Mimetas Major Business
9.2.3 Mimetas Kidney Chip Product and Services
9.2.4 Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mimetas Recent Developments/Updates
9.2.6 Mimetas Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Kidney Chip Product and Services
9.3.4 TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 Valo Health
9.4.1 Valo Health Details
9.4.2 Valo Health Major Business
9.4.3 Valo Health Kidney Chip Product and Services
9.4.4 Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Valo Health Recent Developments/Updates
9.4.6 Valo Health Competitive Strengths & Weaknesses
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Details
9.5.2 CN Bio Innovations Major Business
9.5.3 CN Bio Innovations Kidney Chip Product and Services
9.5.4 CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CN Bio Innovations Recent Developments/Updates
9.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.6 Draper Laboratory
9.6.1 Draper Laboratory Details
9.6.2 Draper Laboratory Major Business
9.6.3 Draper Laboratory Kidney Chip Product and Services
9.6.4 Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Draper Laboratory Recent Developments/Updates
9.6.6 Draper Laboratory Competitive Strengths & Weaknesses
9.7 Nortis
9.7.1 Nortis Details
9.7.2 Nortis Major Business
9.7.3 Nortis Kidney Chip Product and Services
9.7.4 Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nortis Recent Developments/Updates
9.7.6 Nortis Competitive Strengths & Weaknesses
9.8 Xona Microfluidics
9.8.1 Xona Microfluidics Details
9.8.2 Xona Microfluidics Major Business
9.8.3 Xona Microfluidics Kidney Chip Product and Services
9.8.4 Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Xona Microfluidics Recent Developments/Updates
9.8.6 Xona Microfluidics Competitive Strengths & Weaknesses
9.9 SynVivo
9.9.1 SynVivo Details
9.9.2 SynVivo Major Business
9.9.3 SynVivo Kidney Chip Product and Services
9.9.4 SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SynVivo Recent Developments/Updates
9.9.6 SynVivo Competitive Strengths & Weaknesses
9.10 Beijing Daxiang Biotech
9.10.1 Beijing Daxiang Biotech Details
9.10.2 Beijing Daxiang Biotech Major Business
9.10.3 Beijing Daxiang Biotech Kidney Chip Product and Services
9.10.4 Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Beijing Daxiang Biotech Recent Developments/Updates
9.10.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Kidney Chip Industry Chain
10.2 Kidney Chip Upstream Analysis
10.3 Kidney Chip Midstream Analysis
10.4 Kidney Chip Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Kidney Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Kidney Chip Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Kidney Chip Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Kidney Chip Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Kidney Chip Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Kidney Chip Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Kidney Chip Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Kidney Chip Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Kidney Chip Players in 2025
Table 12. World Kidney Chip Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Kidney Chip Company Evaluation Quadrant
Table 14. Head Office of Key Kidney Chip Players
Table 15. Kidney Chip Market: Company Product Type Footprint
Table 16. Kidney Chip Market: Company Product Application Footprint
Table 17. Kidney Chip Mergers & Acquisitions Activity
Table 18. United States VS China Kidney Chip Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Kidney Chip Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Kidney Chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Kidney Chip Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 23. China Based Kidney Chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Kidney Chip Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 26. Rest of World Based Kidney Chip Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Kidney Chip Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 29. World Kidney Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Kidney Chip Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Kidney Chip Market Size by Type (2027-2032) & (USD Million)
Table 32. World Kidney Chip Market Size by Channel, (USD Million), 2021 & 2025 & 2032
Table 33. World Kidney Chip Market Size Value by Channel (2021-2026) & (USD Million)
Table 34. World Kidney Chip Market Size by Channel (2027-2032) & (USD Million)
Table 35. World Kidney Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Kidney Chip Market Size Value by Source (2021-2026) & (USD Million)
Table 37. World Kidney Chip Market Size by Source (2027-2032) & (USD Million)
Table 38. World Kidney Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Kidney Chip Market Size by Application (2021-2026) & (USD Million)
Table 40. World Kidney Chip Market Size by Application (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Kidney Chip Product and Services
Table 44. Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Manufacturing Base and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Kidney Chip Product and Services
Table 50. Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Kidney Chip Product and Services
Table 56. TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. Valo Health Basic Information, Manufacturing Base and Competitors
Table 60. Valo Health Major Business
Table 61. Valo Health Kidney Chip Product and Services
Table 62. Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Valo Health Recent Developments/Updates
Table 64. Valo Health Competitive Strengths & Weaknesses
Table 65. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 66. CN Bio Innovations Major Business
Table 67. CN Bio Innovations Kidney Chip Product and Services
Table 68. CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CN Bio Innovations Recent Developments/Updates
Table 70. CN Bio Innovations Competitive Strengths & Weaknesses
Table 71. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 72. Draper Laboratory Major Business
Table 73. Draper Laboratory Kidney Chip Product and Services
Table 74. Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Draper Laboratory Recent Developments/Updates
Table 76. Draper Laboratory Competitive Strengths & Weaknesses
Table 77. Nortis Basic Information, Manufacturing Base and Competitors
Table 78. Nortis Major Business
Table 79. Nortis Kidney Chip Product and Services
Table 80. Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nortis Recent Developments/Updates
Table 82. Nortis Competitive Strengths & Weaknesses
Table 83. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 84. Xona Microfluidics Major Business
Table 85. Xona Microfluidics Kidney Chip Product and Services
Table 86. Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Xona Microfluidics Recent Developments/Updates
Table 88. Xona Microfluidics Competitive Strengths & Weaknesses
Table 89. SynVivo Basic Information, Manufacturing Base and Competitors
Table 90. SynVivo Major Business
Table 91. SynVivo Kidney Chip Product and Services
Table 92. SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SynVivo Recent Developments/Updates
Table 94. SynVivo Competitive Strengths & Weaknesses
Table 95. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 96. Beijing Daxiang Biotech Major Business
Table 97. Beijing Daxiang Biotech Kidney Chip Product and Services
Table 98. Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Beijing Daxiang Biotech Recent Developments/Updates
Table 100. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 101. Global Key Players of Kidney Chip Upstream (Raw Materials)
Table 102. Global Kidney Chip Typical Customers
Table 1. World Kidney Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Kidney Chip Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Kidney Chip Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Kidney Chip Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Kidney Chip Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Kidney Chip Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Kidney Chip Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Kidney Chip Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Kidney Chip Players in 2025
Table 12. World Kidney Chip Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Kidney Chip Company Evaluation Quadrant
Table 14. Head Office of Key Kidney Chip Players
Table 15. Kidney Chip Market: Company Product Type Footprint
Table 16. Kidney Chip Market: Company Product Application Footprint
Table 17. Kidney Chip Mergers & Acquisitions Activity
Table 18. United States VS China Kidney Chip Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Kidney Chip Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Kidney Chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Kidney Chip Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 23. China Based Kidney Chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Kidney Chip Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 26. Rest of World Based Kidney Chip Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Kidney Chip Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Kidney Chip Revenue Market Share (2021-2026)
Table 29. World Kidney Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Kidney Chip Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Kidney Chip Market Size by Type (2027-2032) & (USD Million)
Table 32. World Kidney Chip Market Size by Channel, (USD Million), 2021 & 2025 & 2032
Table 33. World Kidney Chip Market Size Value by Channel (2021-2026) & (USD Million)
Table 34. World Kidney Chip Market Size by Channel (2027-2032) & (USD Million)
Table 35. World Kidney Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Table 36. World Kidney Chip Market Size Value by Source (2021-2026) & (USD Million)
Table 37. World Kidney Chip Market Size by Source (2027-2032) & (USD Million)
Table 38. World Kidney Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Kidney Chip Market Size by Application (2021-2026) & (USD Million)
Table 40. World Kidney Chip Market Size by Application (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Kidney Chip Product and Services
Table 44. Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Manufacturing Base and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Kidney Chip Product and Services
Table 50. Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Kidney Chip Product and Services
Table 56. TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. Valo Health Basic Information, Manufacturing Base and Competitors
Table 60. Valo Health Major Business
Table 61. Valo Health Kidney Chip Product and Services
Table 62. Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Valo Health Recent Developments/Updates
Table 64. Valo Health Competitive Strengths & Weaknesses
Table 65. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 66. CN Bio Innovations Major Business
Table 67. CN Bio Innovations Kidney Chip Product and Services
Table 68. CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CN Bio Innovations Recent Developments/Updates
Table 70. CN Bio Innovations Competitive Strengths & Weaknesses
Table 71. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 72. Draper Laboratory Major Business
Table 73. Draper Laboratory Kidney Chip Product and Services
Table 74. Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Draper Laboratory Recent Developments/Updates
Table 76. Draper Laboratory Competitive Strengths & Weaknesses
Table 77. Nortis Basic Information, Manufacturing Base and Competitors
Table 78. Nortis Major Business
Table 79. Nortis Kidney Chip Product and Services
Table 80. Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nortis Recent Developments/Updates
Table 82. Nortis Competitive Strengths & Weaknesses
Table 83. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 84. Xona Microfluidics Major Business
Table 85. Xona Microfluidics Kidney Chip Product and Services
Table 86. Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Xona Microfluidics Recent Developments/Updates
Table 88. Xona Microfluidics Competitive Strengths & Weaknesses
Table 89. SynVivo Basic Information, Manufacturing Base and Competitors
Table 90. SynVivo Major Business
Table 91. SynVivo Kidney Chip Product and Services
Table 92. SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SynVivo Recent Developments/Updates
Table 94. SynVivo Competitive Strengths & Weaknesses
Table 95. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 96. Beijing Daxiang Biotech Major Business
Table 97. Beijing Daxiang Biotech Kidney Chip Product and Services
Table 98. Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Beijing Daxiang Biotech Recent Developments/Updates
Table 100. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 101. Global Key Players of Kidney Chip Upstream (Raw Materials)
Table 102. Global Kidney Chip Typical Customers
LIST OF FIGURES
Figure 1. Kidney Chip Picture
Figure 2. World Kidney Chip Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Kidney Chip Total Revenue (2021-2032) & (USD Million)
Figure 4. World Kidney Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Kidney Chip Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 13. Kidney Chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 16. World Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 18. China Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 23. India Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Kidney Chip by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Kidney Chip Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Kidney Chip Markets in 2025
Figure 27. United States VS China: Kidney Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Kidney Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Kidney Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Kidney Chip Market Size Market Share by Type in 2025
Figure 31. Glomerulus-on-a-Chip
Figure 32. Renal Tubule-on-a-Chip
Figure 33. Others
Figure 34. World Kidney Chip Market Size Market Share by Type (2021-2032)
Figure 35. World Kidney Chip Market Size by Channel, (USD Million), 2021 & 2025 & 2032
Figure 36. World Kidney Chip Market Size Market Share by Channel in 2025
Figure 37. Single-Channel
Figure 38. Dual-Channel
Figure 39. World Kidney Chip Market Size Market Share by Channel (2021-2032)
Figure 40. World Kidney Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Kidney Chip Market Size Market Share by Source in 2025
Figure 42. Primary Human Cell-Based Type
Figure 43. Immortalized Cell Line-Based Type
Figure 44. Stem Cell & Organoid-Based Type
Figure 45. World Kidney Chip Market Size Market Share by Source (2021-2032)
Figure 46. World Kidney Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Kidney Chip Market Size Market Share by Application in 2025
Figure 48. Hospitals
Figure 49. Research Institutions
Figure 50. Universities
Figure 51. Others
Figure 52. World Kidney Chip Market Size Market Share by Application (2021-2032)
Figure 53. Kidney Chip Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Kidney Chip Picture
Figure 2. World Kidney Chip Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Kidney Chip Total Revenue (2021-2032) & (USD Million)
Figure 4. World Kidney Chip Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Kidney Chip Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Kidney Chip Revenue (2021-2032) & (USD Million)
Figure 13. Kidney Chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 16. World Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 18. China Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 23. India Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Kidney Chip by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Kidney Chip Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Kidney Chip Markets in 2025
Figure 27. United States VS China: Kidney Chip Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Kidney Chip Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Kidney Chip Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Kidney Chip Market Size Market Share by Type in 2025
Figure 31. Glomerulus-on-a-Chip
Figure 32. Renal Tubule-on-a-Chip
Figure 33. Others
Figure 34. World Kidney Chip Market Size Market Share by Type (2021-2032)
Figure 35. World Kidney Chip Market Size by Channel, (USD Million), 2021 & 2025 & 2032
Figure 36. World Kidney Chip Market Size Market Share by Channel in 2025
Figure 37. Single-Channel
Figure 38. Dual-Channel
Figure 39. World Kidney Chip Market Size Market Share by Channel (2021-2032)
Figure 40. World Kidney Chip Market Size by Source, (USD Million), 2021 & 2025 & 2032
Figure 41. World Kidney Chip Market Size Market Share by Source in 2025
Figure 42. Primary Human Cell-Based Type
Figure 43. Immortalized Cell Line-Based Type
Figure 44. Stem Cell & Organoid-Based Type
Figure 45. World Kidney Chip Market Size Market Share by Source (2021-2032)
Figure 46. World Kidney Chip Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Kidney Chip Market Size Market Share by Application in 2025
Figure 48. Hospitals
Figure 49. Research Institutions
Figure 50. Universities
Figure 51. Others
Figure 52. World Kidney Chip Market Size Market Share by Application (2021-2032)
Figure 53. Kidney Chip Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
